Leonard Weiner profile picture
315 464-1996

Leonard Weiner, MD

CURRENT APPOINTMENTS

Distinguished Service Professor of Pediatrics
Professor of Pathology

SPECIALTIES

Pediatrics
Pediatric Infectious Diseases

LANGUAGES

English

PATIENT TYPE

Adults and Children

CLINICAL BACKGROUND AND MY APPROACH TO CARE

Pediatric infections, immunizations, Pediatric HIV, new antibiotics

CLINICAL TRIALS

A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in Healthy Infants
Read more
A Phase 3, Multi-center, Open-Label, Randomized, Comparator-Controlled Trial of the Safety and Efficacy of Dalbavancin versus Active Comparator in Pediatric Subjects with Acute Bacterial Skin and Skin Structure Infections
Read more
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Read more
A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral naïve HIV-1 infected adolescents and children aged ≥6 to <18 years
Read more
Analysis of Existing Newborn Screening Specimens from Children Diagnosed with B Cell Immunodeficiencies or Lymphopenia
Read more
A Phase I-II, Randomized, Double-Blind, Study to Evaluate the Safety, Tolerability, and Immunogenicity of Different Formulations of V114 in Healthy Adults and Infants
Read more
A retrospective chart review of disease markers and treatment measures in pediatric Hepatitis A, B and C patients to identify consistent disease parameters for use in clinical management.
Read more
A phase IIIA, randomized, observer-blind, controlled, multinational study to evaluate the safety and immunogenicity of GSK Biologicals' MMR vaccine (209762) (Priorix®) compared to Merck & Co., Inc.￿s MMR vaccine (M-M-R®II or VaxPro), as a first dose, both co-administered with Varivax, Havrix (all subjects) and Prevnar 13 (US subset) in healthy children 12 to 15 months of age.
Read more
A Multicenter, Randomized, Double-Blinded Comparative Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daptomycin Versus Active Comparator in Pediatric Subjects with Acute Hematogenous Osteomyelitis Due to Gram-Positive Organisms.
Read more
A Phase 2/3Multicenter, Open-Label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG) Administered with a Background Regimen (BR) Containing a Ritinavir-Boosted Protease Inhibitor (PI/r) in HIV-1 Infected, Antiretroviral Treatment-Experienced Pediatric Subjects.
Read more
A Phase 2/3Multicenter, Open-Label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK) Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co), Administered with an Optimized Background Regimen (BR) in HIV-1 Infected, Treatment-Experienced, Viroligically Suppressed Pediatric Subjects.
Read more
An Open Label, Randomized, Adaptive, Two-Arm, Multicenter Trial to Evaluate Pharmackinetics and Pharmacodynamics of Two Doses of Oseltamivir (Tamilflu) in the Treatment of Influenza in Immunocompromised Children, Less than 13 Years of Age, with Confirmed Influenza Infection.
Read more

DISEASES & CONDITIONS TREATED

Antibiotic-Associated Diarrhea
Antibiotic-Resistant Infections
Bacterial Meningitis in Children
Fever
Giardiasis
Herpes Encephalitis
HIV Infection and AIDS
Immune Abnormalities
Infections of Bones and Joints
Infectious Mononucleosis
Infective Endocarditis
Pneumonia
Shingles
Tuberculosis (TB)
Viral Infections in Children
Viral Meningitis in Children
Yeast Infection or Candidiasis

CLINICAL AFFILIATIONS

Physicians' Office Building
725 Irving Avenue
Syracuse, NY 13210
315 464-1996
Physicians' Office Building
725 Irving Avenue
Syracuse, NY 13210
315 464-6331

CLINICAL SECTION AFFILIATIONS

Pediatrics
Immunology and Infectious Disease

CURRENT HOSPITAL PRIVILEGES

Upstate University Hospital
Crouse Hospital

CAMPUSES

Downtown